2016
DOI: 10.18293/seke2016-048
|View full text |Cite
|
Sign up to set email alerts
|

Improving Accuracy of Patient Synthetic Data for Testing Medical Cyber-Physical Systems

Abstract: Medical Cyber-Physical Systems (MCPS) integrate the cyber space and physical world elements for promoting support for health assurance activities. MCPS are life-critical systems, demanding a strong engineering effort to guarantee safety, what directly impacts on testing process. Testing MCPS using real patients is very expensive and complex, since their lives are involved. Thus, the use of patient synthetic data becomes a promising approach. In this paper we propose a model for improving accuracy of patient sy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Although there are disadvantages to using routinely collected data for research, there are also advantages beyond the ease and cost of collection. There is a move towards the greater use of real‐world data, particularly in assessment of drug efficacy and adverse effects, because it represents actual practice (where a more heterogeneous population is treated, with polypharmacy, co‐morbidities and extremes of age commonplace) . The ‘V’ of ‘Velocity’ in Big Data makes it possible to find out what is happening to individuals as it happens, which has many applications in detecting adverse effects or epidemics, for example.…”
Section: Big Data Definedmentioning
confidence: 99%
“…Although there are disadvantages to using routinely collected data for research, there are also advantages beyond the ease and cost of collection. There is a move towards the greater use of real‐world data, particularly in assessment of drug efficacy and adverse effects, because it represents actual practice (where a more heterogeneous population is treated, with polypharmacy, co‐morbidities and extremes of age commonplace) . The ‘V’ of ‘Velocity’ in Big Data makes it possible to find out what is happening to individuals as it happens, which has many applications in detecting adverse effects or epidemics, for example.…”
Section: Big Data Definedmentioning
confidence: 99%